Miroslav Levý

1.6k total citations
55 papers, 1.2k citations indexed

About

Miroslav Levý is a scholar working on Molecular Biology, Cancer Research and Oncology. According to data from OpenAlex, Miroslav Levý has authored 55 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 24 papers in Molecular Biology, 23 papers in Cancer Research and 22 papers in Oncology. Recurrent topics in Miroslav Levý's work include Genetic factors in colorectal cancer (17 papers), Cancer-related molecular mechanisms research (11 papers) and Colorectal Cancer Treatments and Studies (11 papers). Miroslav Levý is often cited by papers focused on Genetic factors in colorectal cancer (17 papers), Cancer-related molecular mechanisms research (11 papers) and Colorectal Cancer Treatments and Studies (11 papers). Miroslav Levý collaborates with scholars based in Czechia, Italy and Germany. Miroslav Levý's co-authors include Pavel Vodička, Ludmila Lipská, Ľudmila Vodičková, Alessio Naccarati, Václav Liška, Jana Slyšková, Barbara Pardini, Michaela Schneiderová, Veronika Vymetálková and Tomáš Büchler and has published in prestigious journals such as Gastroenterology, PLoS ONE and Cancer.

In The Last Decade

Miroslav Levý

52 papers receiving 1.2k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Miroslav Levý Czechia 21 758 665 337 208 144 55 1.2k
Xi‐Dai Long China 22 793 1.0× 480 0.7× 190 0.6× 102 0.5× 107 0.7× 65 1.2k
Qian Xu China 23 838 1.1× 668 1.0× 155 0.5× 115 0.6× 240 1.7× 80 1.4k
Kimishige Akino Japan 15 933 1.2× 219 0.3× 277 0.8× 149 0.7× 142 1.0× 24 1.3k
Jiandong Wang China 16 635 0.8× 687 1.0× 121 0.4× 68 0.3× 81 0.6× 37 989
F Anthony San Lucas United States 9 917 1.2× 761 1.1× 469 1.4× 48 0.2× 106 0.7× 10 1.4k
Leslie J. Krueger United States 12 655 0.9× 487 0.7× 122 0.4× 87 0.4× 148 1.0× 21 1.0k
Gunnar Adell Sweden 19 404 0.5× 211 0.3× 589 1.7× 243 1.2× 171 1.2× 41 1.1k
Eung Bae Lee South Korea 20 544 0.7× 286 0.4× 369 1.1× 75 0.4× 653 4.5× 56 1.1k
B.J. Moss United States 11 691 0.9× 309 0.5× 209 0.6× 91 0.4× 767 5.3× 16 1.3k
S Grandjouan France 15 431 0.6× 244 0.4× 368 1.1× 414 2.0× 113 0.8× 37 1.0k

Countries citing papers authored by Miroslav Levý

Since Specialization
Citations

This map shows the geographic impact of Miroslav Levý's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Miroslav Levý with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Miroslav Levý more than expected).

Fields of papers citing papers by Miroslav Levý

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Miroslav Levý. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Miroslav Levý. The network helps show where Miroslav Levý may publish in the future.

Co-authorship network of co-authors of Miroslav Levý

This figure shows the co-authorship network connecting the top 25 collaborators of Miroslav Levý. A scholar is included among the top collaborators of Miroslav Levý based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Miroslav Levý. Miroslav Levý is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Pálek, Richard, Jan Brůha, Miroslav Levý, et al.. (2025). Dysregulated mitochondrial homeostasis and DNA repair in the progression from colon adenoma to cancer. Molecular Medicine. 31(1). 341–341.
2.
Novosadová, Vendula, et al.. (2024). Plasma miR-122-5p and miR-142-5p and their role in chemoresistance of patients with colon cancer. Mutagenesis. 40(1). 80–86. 2 indexed citations
3.
Čumová, Andrea, Ľudmila Vodičková, Miroslav Levý, et al.. (2022). MiR-140 leads to MRE11 downregulation and ameliorates oxaliplatin treatment and therapy response in colorectal cancer patients. Frontiers in Oncology. 12. 959407–959407. 6 indexed citations
4.
Shapira, Shiran, Dina Kazanov, Miroslav Levý, et al.. (2020). O-15 The dark age of single organ screening is over: CD24 is a novel universal simple blood test for early detection of cancer. Annals of Oncology. 31. 237–237. 1 indexed citations
5.
Lu, Shun, Stefanie Huhn, Barbara Pardini, et al.. (2019). Single nucleotide polymorphisms within MUC4 are associated with colorectal cancer survival. PLoS ONE. 14(5). e0216666–e0216666. 15 indexed citations
6.
Filho, Miguel Inácio da Silva, Frank Christoph, Shun Lu, et al.. (2019). Epistatic effect of TLR3 and cGAS‐STING‐IKKε‐TBK1‐IFN signaling variants on colorectal cancer risk. Cancer Medicine. 9(4). 1473–1484. 12 indexed citations
7.
Kunzmann, Andrew T., Kateřina Jirásková, Michaela Schneiderová, et al.. (2019). Fusobacterium nucleatum tumor DNA levels are associated with survival in colorectal cancer patients. European Journal of Clinical Microbiology & Infectious Diseases. 38(10). 1891–1899. 47 indexed citations
8.
Jirásková, Kateřina, David J. Hughes, Stefanie Brezina, et al.. (2018). Functional Polymorphisms in DNA Repair Genes Are Associated with Sporadic Colorectal Cancer Susceptibility and Clinical Outcome. International Journal of Molecular Sciences. 20(1). 97–97. 21 indexed citations
9.
Vodenková, Soňa, Kateřina Jirásková, Markéta Urbanová, et al.. (2018). Base excision repair capacity as a determinant of prognosis and therapy response in colon cancer patients. DNA repair. 72. 77–85. 27 indexed citations
10.
Filho, Miguel Inácio da Silva, Frank Christoph, Kateřina Jirásková, et al.. (2018). Investigation of single and synergic effects of NLRC5 and PD-L1 variants on the risk of colorectal cancer. PLoS ONE. 13(2). e0192385–e0192385. 23 indexed citations
11.
Benešová, Lucie, Barbora Belšánová, Miroslav Levý, et al.. (2016). Monitoring of Circulating Tumor Cells by a Combination of Immunomagnetic Enrichment and RT-PCR in Colorectal Cancer Patients Undergoing Surgery. Advances in Clinical and Experimental Medicine. 25(6). 1273–1279. 7 indexed citations
12.
Korenková, Vlasta, Jana Slyšková, Vendula Novosadová, et al.. (2016). The focus on sample quality: Influence of colon tissue collection on reliability of qPCR data. Scientific Reports. 6(1). 29023–29023. 7 indexed citations
13.
Slyšková, Jana, Francesca Cordero, Barbara Pardini, et al.. (2014). Post‐treatment recovery of suboptimal DNA repair capacity and gene expression levels in colorectal cancer patients. Molecular Carcinogenesis. 54(9). 769–778. 16 indexed citations
14.
Pardini, Barbara, Fabio Rosa, Elisa Barone, et al.. (2013). Variation within 3′-UTRs of Base Excision Repair Genes and Response to Therapy in Colorectal Cancer Patients: A Potential Modulation of microRNAs Binding. Clinical Cancer Research. 19(21). 6044–6056. 46 indexed citations
15.
Slyšková, Jana, Vlasta Korenková, Andrew Collins, et al.. (2012). Functional, Genetic, and Epigenetic Aspects of Base and Nucleotide Excision Repair in Colorectal Carcinomas. Clinical Cancer Research. 18(21). 5878–5887. 62 indexed citations
16.
Naccarati, Alessio, Barbara Pardini, Stefano Landi, et al.. (2012). Polymorphisms in miRNA-binding sites of nucleotide excision repair genes and colorectal cancer risk. Carcinogenesis. 33(7). 1346–1351. 54 indexed citations
17.
Slyšková, Jana, Alessio Naccarati, Barbara Pardini, et al.. (2012). Differences in nucleotide excision repair capacity between newly diagnosed colorectal cancer patients and healthy controls. Mutagenesis. 27(2). 225–232. 38 indexed citations
18.
Benešová, Lucie, Barbora Belšánová, Štěpán Suchánek, et al.. (2012). Mutation-based detection and monitoring of cell-free tumor DNA in peripheral blood of cancer patients. Analytical Biochemistry. 433(2). 227–234. 89 indexed citations
19.
Sealy, R., et al.. (1977). The prediction of tumor regression in human squamous carcinoma by means of the potential tumor doubling time. Cancer. 39(5). 2275–2279. 3 indexed citations
20.
Pierre‐Kahn, Alain, et al.. (1973). Glomérulonéphrites des dérivations ventriculo-atriales.. Neurochirurgie. 19(4). 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Xi‐Dai Long Breakdown of academic impact, for papers by Qian Xu Breakdown of academic impact, for papers by Kimishige Akino Breakdown of academic impact, for papers by Jiandong Wang Breakdown of academic impact, for papers by F Anthony San Lucas Breakdown of academic impact, for papers by Leslie J. Krueger Breakdown of academic impact, for papers by Gunnar Adell Breakdown of academic impact, for papers by Eung Bae Lee Breakdown of academic impact, for papers by B.J. Moss Breakdown of academic impact, for papers by S Grandjouan
Rankless by CCL
2026